Fiche société
MED Institute Inc.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)The primary objective of this study is to provide UC-MSC treatment to patients with DMD. Secondary objectives will be to further evaluate treatment-related adverse events as well as changes in DMD-related functional testing/assessments, blood laboratories, and inflammation related biomarker levels over time. | Myopathies | Phase 2 | Thérapie cellulaire | United States | À vérifier |
| Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)The primary objective of this study is to provide UC-MSC treatment to patients with DMD. Secondary objectives will be to further evaluate treatment-related adverse events as well as changes in DMD-related functional testing/assessments, blood laboratories, and inflammation related biomarker levels over time. | Myopathies | Phase 2 | Thérapie cellulaire | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) | Myopathies | Phase 2 | NCT06579352 | Study of UC-MSC in DMD Patients | ACTIVE_NOT_RECRUITING |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) | Subconjunctival Injection of Mesenchymal Stem Cells for Corneal Wound Healing After Chemical Injury: Impact on Epithelial Coverage, Limbal Ischemia, and Ocular Surface Inflammatory. | Frontiers in medicine | ||
| Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) | Bone marrow mesenchymal stem cell exosomes in osteonecrosis: pathological mechanisms and therapeutic strategies. | Molecular biology reports |